K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 7, Pages 831-842
Publisher
Informa Healthcare
Online
2015-12-21
DOI
10.1517/14728222.2016.1135131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Design of Covalent Allosteric Drugs
- (2015) Ruth Nussinov et al. Annual Review of Pharmacology and Toxicology
- An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions
- (2015) Chun-Yen Liu et al. APOPTOSIS
- High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
- (2015) Tanmay S. Chavan et al. BIOPHYSICAL JOURNAL
- A New View of Ras Isoforms in Cancers
- (2015) R. Nussinov et al. CANCER RESEARCH
- Inhibitors of Ras-SOS Interactions
- (2015) Shaoyong Lu et al. ChemMedChem
- Metabolic Dependencies in RAS-Driven Cancers
- (2015) A. C. Kimmelman CLINICAL CANCER RESEARCH
- Direct Attack on RAS: Intramolecular Communication and Mutation-Specific Effects
- (2015) K. Marcus et al. CLINICAL CANCER RESEARCH
- RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
- (2015) J. Downward CLINICAL CANCER RESEARCH
- Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
- (2015) A. D. Cox et al. CLINICAL CANCER RESEARCH
- ‘Latent drivers’ expand the cancer mutational landscape
- (2015) Ruth Nussinov et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results
- (2015) Alice Pasini et al. DRUGS
- A review on anticancer potential of bioactive heterocycle quinoline
- (2015) Obaid Afzal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer
- (2015) Kenneth K.W. To et al. EXPERIMENTAL CELL RESEARCH
- Evading inhibitory constraints - destabilizing p110α/p85α interactions
- (2015) Clare Sheridan FEBS Journal
- Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region
- (2015) Hyunbum Jang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site
- (2015) Shaoyong Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites
- (2015) Ragul Gowthaman et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
- (2015) R. Nussinov et al. MOLECULAR CANCER RESEARCH
- RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer
- (2015) Gorjan Hrustanovic et al. NATURE MEDICINE
- Targeting KRAS and the vitamin D receptor via microtubules
- (2015) Agnes Basseville et al. Nature Reviews Clinical Oncology
- Regulation of RAF protein kinases in ERK signalling
- (2015) Hugo Lavoie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- YAP Regulates S-Phase Entry in Endothelial Cells
- (2015) Zhewei Shen et al. PLoS One
- Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway
- (2015) Xiaolin Nan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif
- (2015) Frederick D. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
- (2015) Marianne S. Poruchynsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Flexibility and small pockets at protein–protein interfaces: New insights into druggability
- (2015) Harry Jubb et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Stabilization of Protein–Protein Interactions in chemical biology and drug discovery
- (2015) David Bier et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Helix mimetics: Recent developments
- (2015) Andrew J. Wilson PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Mechanical strain induces E-cadherin-dependent Yap1 and -catenin activation to drive cell cycle entry
- (2015) B. W. Benham-Pyle et al. SCIENCE
- Novel Targets in Pancreatic Cancer Research
- (2015) Geoffrey Kozak et al. SEMINARS IN ONCOLOGY
- GTP-Dependent K-Ras Dimerization
- (2015) Serena Muratcioglu et al. STRUCTURE
- Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
- (2015) F. Skoulidis et al. Cancer Discovery
- Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
- (2015) E. Gabriela Chiorean et al. Drug Design Development and Therapy
- Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells
- (2015) Shoujie Chai et al. Oncotarget
- Molecular landscape of pancreatic cancer: implications for current clinical trials
- (2015) Gregory M. Heestand et al. Oncotarget
- Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
- (2015) Meghan Shea et al. Therapeutic Advances in Respiratory Disease
- A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells
- (2015) V Bhattacharjee et al. CELL CYCLE
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smarter drugs emerging in pancreatic cancer therapy
- (2014) A. Kleger et al. ANNALS OF ONCOLOGY
- Searching for protein binding sites from Molecular Dynamics simulations and paramagnetic fragment-based NMR studies
- (2014) Andrea Bernini et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Not just gRASping at flaws: Finding vulnerabilities to develop novel therapies for treatingKRASmutant cancers
- (2014) Hiromichi Ebi et al. CANCER SCIENCE
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- Small-Molecule Inhibitors That Target Protein-Protein Interactions in the RAD51 Family of Recombinases
- (2014) Duncan E. Scott et al. ChemMedChem
- Brief overview of selected approaches in targeting pancreatic adenocarcinoma
- (2014) Wesley R Samore et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer
- (2014) Bo Mi Ku et al. INVESTIGATIONAL NEW DRUGS
- A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand
- (2014) Qi Sun et al. JOURNAL OF BIOMOLECULAR NMR
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC)
- (2014) D. R. P. Sauter et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- KRAS: feeding pancreatic cancer proliferation
- (2014) Kirsten L. Bryant et al. TRENDS IN BIOCHEMICAL SCIENCES
- Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
- (2014) Yingxi Xu et al. TRENDS IN BIOCHEMICAL SCIENCES
- Unraveling structural mechanisms of allosteric drug action
- (2014) Ruth Nussinov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities
- (2014) Paul A. Hubbard et al. Frontiers in Physiology
- PQ1, a quinoline derivative, induces apoptosis in T47D breast cancer cells through activation of caspase-8 and caspase-9
- (2013) Ying Ding et al. APOPTOSIS
- The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer
- (2013) Martin W. Berchtold et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A broad view of scaffolding suggests that scaffolding proteins can actively control regulation and signaling of multienzyme complexes through allostery
- (2013) Ruth Nussinov et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Allostery in Disease and in Drug Discovery
- (2013) Ruth Nussinov et al. CELL
- Using a Fragment-Based Approach To Target Protein-Protein Interactions
- (2013) Duncan E. Scott et al. CHEMBIOCHEM
- Protein–protein interactions as druggable targets: recent technological advances
- (2013) Alicia P Higueruelo et al. CURRENT OPINION IN PHARMACOLOGY
- Adjuvant Pharmacotherapy in the Management of Elderly Patients with Pancreatic Cancer
- (2013) Raphaël Maréchal et al. DRUGS & AGING
- TRAPP: A Tool for Analysis of Transient Binding Pockets in Proteins
- (2013) Daria B. Kokh et al. Journal of Chemical Information and Modeling
- Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators
- (2013) Yuanxiang Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- ‘Pathway drug cocktail’: targeting Ras signaling based on structural pathways
- (2013) Ruth Nussinov et al. TRENDS IN MOLECULAR MEDICINE
- New insights into pancreatic cancer biology
- (2012) M. Hidalgo ANNALS OF ONCOLOGY
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- The Different Ways through Which Specificity Works in Orthosteric and Allosteric Drugs
- (2012) Ruth Nussinov et al. CURRENT PHARMACEUTICAL DESIGN
- Compound Activity Prediction Using Models of Binding Pockets or Ligand Properties in 3D
- (2012) Irina Kufareva et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
- (2012) Marcia Irene Canto et al. GASTROENTEROLOGY
- Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
- (2012) Meredith A. Collins et al. JOURNAL OF CLINICAL INVESTIGATION
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
- (2012) Meredith A. Collins et al. PLoS One
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA)
- (2012) J. E. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural biology and drug discovery for protein–protein interactions
- (2012) Harry Jubb et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
- (2011) D. Matthaios et al. ONCOLOGY
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- Dynamic Allostery: Linkers Are Not Merely Flexible
- (2011) Buyong Ma et al. STRUCTURE
- Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer
- (2011) Zhao-Li Chen et al. Chinese Journal of Cancer
- Allostery and population shift in drug discovery
- (2010) Gozde Kar et al. CURRENT OPINION IN PHARMACOLOGY
- Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis
- (2010) A. V. Pinho et al. GUT
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- The Hypervariable Region of K-Ras4B Is Responsible for Its Specific Interactions with Calmodulin
- (2009) Sherwin J. Abraham et al. BIOCHEMISTRY
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B andKRASmutations in colorectal carcinoma
- (2009) Jehad Abubaker et al. JOURNAL OF PATHOLOGY
- A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy
- (2009) Yoshitaka Nakamura et al. Molecular Cancer
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- A frequent kinase domain mutation that changes the interaction between PI3K and the membrane
- (2009) D. Mandelker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2- ]quinoline in colon cancer cells depending on their p53 status
- (2008) M. Sedic et al. MOLECULAR CANCER THERAPEUTICS
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors
- (2008) B. Seidler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis
- (2007) Charles E. Patek et al. EXPERIMENTAL CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search